Glycogen synthase kinase 3β inhibition synergizes with PARP inhibitors through the induction of homologous recombination deficiency in colorectal cancer
Ning Zhang(Chinese Academy of Sciences), Jin‐Xue He(Shanghai Institute of Materia Medica)
Cited by 32
Related Papers
Thioparib inhibits homologous recombination repair, activates the type I IFN response, and overcomes olaparib resistance
|EMBO Molecular Medicine|2023|42